Preoperative Testing Unnecessary for Low-Risk Surgeries
University of Michigan researchers have found evidence suggesting that preoperative testing is often unnecessary for low-risk surgeries.
Read More
Search Results for: lung cancer
Epredia, Aiforia Partner on AI-powered Pathology Software Distribution
Epredia has been appointed as a global distribution partner for Aiforia’s portfolio of preclinical and clinical pathology tools, including segment exclusivity for distribution in the United States.
Read More
Validation Study: Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
The new findings show the Percepta Nasal Swab, a first-of-its-kind genomic test, accurately classifies lung cancer risk in current or former smokers with lung nodules so that those with benign nodules may safely avoid unnecessary additional procedures.
Read More
Severe COVID-19 Detected Earlier by Biomarker
To identify and treat COVID-19 patients at an early stage, predictive biomarkers need to be identified; researchers have discovered one.
Read More
Biodesix Announces Liquid Biopsy NGS Test with 72-Hour Turnaround
The study showed that the rapid liquid biopsy NGS test was able to accurately detect actionable genomic alterations in patients with NSCLC with a turnaround time of only 72 hours.
Read More